Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.73 | -23.37 |
PEG Ratio (TTM) | -3.55 | -7.10 |
P/S Ratio (TTM) | 1,968.41 | 44.34 |
P/B Ratio (TTM) | 2.30 | 33.03 |
P/FCF Ratio (TTM) | -3.17 | -7.73 |
Price to 5YR AVG Earnings Ratio | -3.01 | -7.08 |
Price to 5YR AVG FCF Ratio | -4.78 | -13.02 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -52.69% | -15.67% |
ROE (TTM) | -50.78% | 27.44% |
Net Profit Margin (TTM) | -52,574.84% | -627.99% |
ROIC 5YR AVG | -60.50% | -4.84% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.03% | -127.75% | -73.00% |
Revenue | -60.87% | -15.59% | 292.67% |
Net Income | -0.33% | -193.81% | -112.36% |
Cash Flow | -4.67% | -55.05% | -31.90% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.33 | 5.66 |
Quick Ratio (TTM) | 6.33 | 5.44 |
D/E Ratio (TTM) | N/A | 1.19 |
Interest Coverage (TTM) | -32.62 | -5.92 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 13.21 |
LTL to 5YR AVG FCF | -0.02 | 0.09 |
Shares Outstanding Growth 5YR AVG | 13.43% | 39.51% |